Next-Gen Biotech Innovations for Corporations

---

  We find some companies have recently departed from the classic proven model of 

"Seeking  Excellence", by lowering standards, now tolerating sloppy behaviors and performance  that would never have been allowed in the past.  This comes down to hiring.  This will either be upgraded, or the company will fall behind.   The Team for the project, department or spin-off must be the best possible.

Companies have failed to properly vet some recent hires in the last decade. Too many “alleged” scientists, technicians, lab or project managers... have questionable, inadequate or even fake credentials, lack training and experience, don't know the science, did not learn enough, or were hired for the wrong reasons (policy, not pure excellence),--  sometimes recommended by friends, biased or corrupt people or agencies.

Our TopPhD-BiotechConsultants-tm  need only a couple of hours to determine if a scientist, technician, manager or staffer has real credentials, or real abilities and knowledge.

There is nothing worse in a company than unqualified co-workers or management, dragging down and demoralizing others, faking results or misunderstanding the science.

Top experts can barely understand advanced science.  Anyone less on a project usually means disaster and no progress.  

Likewise, a few days of investigation can determine whether the innovation group, team, project, lab, production or alliance venture... is operating near optimum levels.

We can suggest goals and measures to make sure improvements are continual.

[1] “Advice” as used here, in this field with inherent high risks, is suggestions and opinion only.

A Top Consultant assists ...

… due diligence of your project, acquisition, spin off or partnering for each step 

from concept to monetization to scaling, in areas that only a scientific expert with certain skills and credentials, versed in business also--- can discern.

 
It requires high knowledge of biochemistry, biophysics and biological processes.. . for real innovation in life science/biotech that leads to scalability:

Outside vetting, review and oversight of lab procedures and protocols of your new idea, venture, project or bio-process--- is like insurance against some risks of failure. 

We specialize in examining scientific basis and rationale, proof of concept, (by posing right questions and methods), research, development- or invention perfection, ---

from pre-startup--- through all Stages of finance, or troubleshooting/turn-around / review and upgrading corporate performance.

Typically, lab management, project management and standards adherence are weak

Efficiency and quality can usually be improved.

We have a particular TopPhD-BiotechConsultant-tm  educated also  in business, analysis, statistics and AI to apply  methods used in industrial Quality Assurance/ Quality Control and by efficiency experts--- 

to bear upon:

• team  building and groups coordination,
• project  viability- analysis of potential, and what aspect of the product/process      may excell.  SWOT Analysis;
• selection  or review of lead scientists;
• protocols  and procedures;
• project  management;
• plan,   procedure and protocol adherence, (documentation, QA,      quality control,etc. )
• Finding   optimum “embodiments” for new technology, trade secrets and inventions
• Biotech  invention “perfection assistant”; 
• Finding  bottlenecks and obstacles (sometimes people) and solutions;
• General  oversight;
• 
  

Every Executive needs their observer-overseer and troubleshooter to review standards and adherence thereto;  Also to dig out waste, corruption or “self-interest”.

A main goal of executives is toiImprove: innovation, efficiency, morale and productivity. 

Try us out with a preliminary “spot checking” or brief review.

See our reasonable pricing below, bottom, more described at the bottom of Scientists page.

Finding... new niches, products and strategic partnering or acquisitions--- is necessary to 

stay ahead of the rapid pace of bio-technology; 

If the potential is large (i.e: likely “material” to profits (3%+ affect typically)). there is a duty to examine that.

NOTE: Shareholders are coming with concerns that “profits”, competence of staffing and innovation, results and productivity-- have not taken proper priority.

That must be reviewed, overseen, reported on, fixed and streamlined with capable advisors, especially the science research, development, innovation... and efficiency in manufacturing or process. 

Innovation departments and R&D are NOT meant to be only "cost centers".

Dealing with sensitive scientists, engineers, technicians and lab and project managers--- requires a certain authority (like some of our consultant’s credentials) and sometimes a “kid glove” manner of addressing shortcomings, usually best by showing empathy, informing of executives “new” priorities, and explaining that the Consultant is here “to help”. (Which is generally true, although it may mean reporting on serious staff or performance deficiencies)

GO or NO GO: Do you really want to Improve?

Improvment and innovation are a "core culture" of winning companies.